Enerisant HCl
Enerisant HCl is the salt form of Enerisant, a histamine H3 receptor antagonist. In H3 receptor binding assay using (R)-α-methyl[3H]histamine, Enerisant showed IC50 of 4.9 nM. Enerisant may be useful for the treatment of Alzheimer's disease, schizophrenia, etc.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD1509 |
| CAS # | 152749-07-9 (HCl) |
| Pricing | Customizable size, Inquiry |
| Synonym | Enerisant HCl; Enerisant hydrochloride; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C22H31ClN4O3 |
| Molecular Weight | 434.97 |
| Elemental Analysis | C, 60.75; H, 7.18; Cl, 8.15; N, 12.88; O, 11.03 |
| IUPAC/Chemical Name | Methanone, (1-(4-(3-((2R)-2-methyl-1-pyrrolidinyl)propoxy)phenyl)-1H-pyrazol-4-yl)-4-morpholinyl-, hydrochloride (1:1) |
| InChi Key | QVMTVPSORZKQPZ-GMUIIQOCSA-N |
| InChi Code | InChI=1S/C22H30N4O3.ClH/c1-18-4-2-9-24(18)10-3-13-29-21-7-5-20(6-8-21)26-17-19(16-23-26)22(27)25-11-14-28-15-12-25;/h5-8,16-18H,2-4,9-15H2,1H3;1H/t18-;/m1./s1 |
| SMILES Code | O=C(C1=CN(C2=CC=C(OCCCN3[C@H](C)CCC3)C=C2)N=C1)N4CCOCC4.[H]Cl |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | To be determined |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | To be determined |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |